Related Articles
Strong impact of pathological node‑negative on long‑term overall survival of patients with triple‑negative breast cancer receiving neoadjuvant chemotherapy
Association between the methylation status of PCDH17 and the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer
SIRT5 as a biomarker for response to anthracycline-taxane-based neoadjuvant chemotherapy in triple-negative breast cancer
Prognostic significance of pathological complete response following neoadjuvant chemotherapy for operable breast cancer
Effect of neoadjuvant chemotherapy in patients with triple-negative breast cancer: A meta-analysis